Eden Research Share Discussion Threads

[littlealbatross2] 05/6/2018 12:31

Thanks Super.
Sean Smith came across as quietly confident to me. I thought (competitor ?) Pam Moronne seemed a might tetchy.

[investingisatrickygame] 05/6/2018 10:46

So they are now talking about precision delivery, integrated products and technology.

What stands out a mile to me is the large dinosaurs that are Bayer and Syngenta vis-à-vis the agility of small companies, such as Eden. The dinosaurs also acknowledge that they will have to go 'outside' to seek these technologies to move forward. This indicates that Eden is well placed for the step-change that is required in the Agribusiness to increase productivity. The Bayer guy, very interesting, also talks about this.

Eden from this discussion would appear to have to their potential major benefit

1) A form of precision delivery in Sustaine for its timed release which the panels recognises as a current and future need
2) Integration capabilities for blending pesticides with bio products and other active ingredients. This bridges the time gap (a long one) from big companies switching from chemical based products to bio's which will then influence politicians and thereafter regulators
3) MRL free products

IF Eden could better convey this message supported by others it would open up the share price tremendously. I think very few people will be aware of this other than a few concentrated and enthusiastic supporters of Eden. The message and frequency of the same needs to multiply many times to give Eden greater awareness, value and credibility city side.

[investingisatrickygame] 05/6/2018 10:22

Thanks Super.

Sean is coming across very well (I am part way through). At 14 minutes he talks about how difficult it is to educate the public on such subjects as ours. Well there is a recognition point that he should extrapolate into investor communications. As I always say, people will not invest in what they do not understand. Teach them and they will come:)

He is now going on to talk about general education and outreach to the public and has just touched on using social media which can be a gamechanger.

So, he is acknowledging that which needs to be done to communicate understanding, but Eden to-date, hasn't really embraced that stance.

Come on Sean, you come across well, so let's communicate to private investors properly and get some value, true value into what is a miserable share price.

[supersonico] 05/6/2018 09:08

Sean Smith Panel Discussion: New technologies, their impact and regulation





…………………………………………………………………………………………………



Monsanto Relied on These ‘Partners’ to Attack Top Cancer Scientists

Background
A key document released in 2017 in legal proceedings against Monsanto describes the corporation’s “preparedness and engagement plan” for the IARC cancer classification for glyphosate, the world’s most widely used agrichemical. The internal Monsanto document — dated Feb. 23, 2015 — assigns more than 20 Monsanto staffers to objectives including “neutralize impact of decision,” “regulator outreach,” “ensure MON POV” and “lead voice in ‘who is IARC’ plus 2B outrage.” On March 20, 2015, IARC announced its decision to classify glyphosate as Group 2A carcinogen, “probably carcinogenic to humans.”

[supersonico] 04/6/2018 19:32

More Californians getting sick from pesticides, according to latest state report
by Californians for Pesticide Reform

Friday Jun 1st, 2018 12:56 PM

Agricultural cases up 50%; Monterey County third highest in California
May 31, 2018 - Illnesses caused by agricultural pesticide exposure in California rose by an astonishing 50% in a single year, according to new data just released by the Department of Pesticide Regulation. The number of agricultural cases categorized as "definite," "probable," and "possible" for pesticide-related illnesses and injuries increased from 265 in 2014 to 397 in 2015. Overall pesticide-related illnesses, including those stemming from non-agricultural exposure, were up 10% over the prior year. DPR’s latest Pesticide Illness Report documented 1,187 cases in 2015, a third of them agricultural. Drift was to blame for most of the agricultural incidents, including one in Kern County that sickened 82 workers.

[investingisatrickygame] 04/6/2018 12:11

It would be nice to hear from Powerscourt on the day and for Eden to give them 5 minutes and allow them to verbalise that which they have done AND will be doing

[northwick] 04/6/2018 11:55

Wishful thinking, Eden has and will continue to disappoint with its communications. The last chairman nodded his head in sympathy with us, the shareholders, and did say the company will improve on this front. Let's see what the next two weeks will bring.

[littlealbatross2] 04/6/2018 11:54

Ever the optimist Investing!
Let's hope so.

[investingisatrickygame] 04/6/2018 11:36

The Eden AGM is 2 weeks this Thursday.

Poor though many of these AIM listed companies are at communication with their base (and critical, share price controlling) investor, they seemingly always communicate around and leading up to the AGM. It's as if they store up the RNS's to deliver at a time when they come face to face with their investor base so as to have good relations before they shut up shop for another year.

With just a short window in front of us, we might reasonably expect an array of news from Eden and hopefully starting this week. No news after so many expectations set would be very poor form to say the least.

Fingers crossed for multiple good news stories.

[supersonico] 03/6/2018 11:44

New emails uncovered through a Freedom of Information Act request reveal that a US Food and Drug Administration scientist found residue from the herbicide glyphosate on nearly every food item tested, including cereals, crackers and honey.

[investingisatrickygame] 01/6/2018 12:12

Hello super,

No I haven't

[supersonico] 01/6/2018 08:17

Good summing up Investing. Stumbled upon Terramera in my research and IKEA GreenTech who have bought a chunk of them .

Have you come across them?




…………………………………

Neonicotinoids; an open letter from scientists to policy makers




………………………………….

The British countryside is being killed by herbicides and insecticides – can anything save it?


…………………………………….

Interesting friends;

[investingisatrickygame] 31/5/2018 21:15

Some interesting points on further read of the Annual Report

New Pesticides cost $300 million to bring to market
Biopesticides cost $10-$15 million to bring to market

The biopesticide market in 2016 was $1.8 billion. However, there is a big difference between biopesticides and 'sustainable' biopesticides. The value of the latter market is not qualified. Eden has sustainable chemistry so I wonder where we sit in the pecking order of this market place?

I thought Bayer's 'Companion Animal Healthcare' was just North America, but it is in the EU too.

I think it is about time Eden shares with shareholders their view of what long-term shareholder value might look like. It is very important for all invested to understand this and have some vision of where their investment might go. Having publicly made the statement in print, might long-term value look like 25p, £1, £2 or something else? Eden could also focus on more immediate and mid-term value too!

I'd personally like to see more realistic remuneration targets. Benchmarking against other AIM companies is irrelevant to me as different sectors, different market caps etc. Remuneration should be based on what Eden can afford and what value the individual brings to Eden.

The equity incentive scheme is based upon the sustainable increase in the share price over the corresponding period of time YET the nil cost share options awarded retrospectively have been at a time of a decreasing share price so there is no alignment between directors and shareholders in this respect. If I have misinterpreted this then someone please correct me. These nil cost share options also provide small incentive to go into the market and spend ones own money.

We could maybe do with another board member who could also sit on the remuneration committee. Small numbers of employees in these companies make to my mind, the remuneration committee a bit of a farce.

[investingisatrickygame] 31/5/2018 09:34

AttyG,

I understand it is nominal value, but why does the Company need the same flexibility as previous years?

1) The Company is further advanced now than ever
2) They have plenty of cash
3) They have, by their own admission, increasing product sales and therefore revenue on Mevalone from existing countries
4) They have new countries on board this year to sell Mevalone
5) TT will deliver product sales revenue this year
6) Bayer will deliver product sales revenue this year
7) There will be related milestone payments to the above and also from Eastman
8) There will possibly be further milestone payments and more this year from Sipcam for the 'very far advanced' work on using their active ingredients in Sustaine


All of the above adds up to a reduced reliance on capital raising and dilution to shareholders. The request to issue a number of shares should have, in my opinion, been substantially less than 33%. For what it is worth, I will vote against this in the absence of greater explanation as to why. With Sipcam on board with a strategic investment it is not out of the question that within the year Eden could take a loan from Sipcam in advance of product sales income from them and others and again this, if used and applicable, would reduce the need for potential substantial dilution.

The figures requested are quite unpalatable. You can't accept these things blindly.

[attyg] 31/5/2018 07:39

I thought the AR read well.

The BoD must believe (and hopefully supported by a good knowledge) that Bayer and TT will actually really deliver before Dec 2018.

This could be a great year for us.

Lots of milestones plus repeatable sales.

Milestones expected
Bayer $800k - see Admission Document;
Sipcam - the multi option agreement period expires 31 Dec 2018 - surely at least another €600k
Eastman - annual milestone

[attyg] 31/5/2018 07:34

Ord Res 5 is the power to allot shares with a nominal value of one penny.

So the nominal value of £729,123.54p of shares is the equivalent of issuing 72,912,354 more shares. This is apparently the "..approximately equal to 33.3% of the Company's issued share capital.." and share options and awards outstanding.

Quite a lot of flexibility being requested by the BoD.

Similar to previous years.

Quite likely the likes of Sipcam, Livingbridge Artemis etc will have already OKd this.

[supersonico] 30/5/2018 23:14

In upcoming Roundup cancer trial, #Monsanto moves to exclude former @EPA staffer Marion Copley's fascinating letter, in which she states that "It is essentially certain that glyphosate causes cancer."

[bjlk] 30/5/2018 22:07

Reasons need to be supplied as to why this is needed.... as a backup and we can't tell you why but jam tomorrow will not suffice... COMMUNICATE with us Eden....FFS

[bjlk] 30/5/2018 22:04

729123.84/mid price 0.1285=5,674,113 new sharesTotal shares in issue 207,189,337 5674113/207189337x100 = 2.74% increase in shares This is still baffling as to why they need this assuming revenues but your maths is really off...

[investingisatrickygame] 30/5/2018 15:19

Very quick observations on the AGM Resolutions and notice issued by RNS today

1) Sean Smith and our new Chairman have clearly not bought any shares in the Company as the Directors commitments are static with Alex Abrey and Robin Cridland

2) Why does Eden want authority to increase the share capital by 33% which is a potentially significant dilution for all of us and in return for a paltry £729,000 nominal value? The effect on us for the return to Eden is massively out of sync and as we have been advised before, unnecessary. Dilute by 33% if you really need cash to further the business, but do it at 50 pence and not again at such a lowly price level, if indeed this is the intention. This 'request' contradicts page 12 of 64 in the annual report "FOR SHAREHOLDERS We are well funded and positioned to deliver long-term shareholder value through further commercialisation and sales of our products"

3) CEO's report - regulatory approvals in both the EU and the US for TT should be completed in H1 2018 with sales in H2 2018. Are we due an associated RNS? Head lice and underarm deodorant!

4) I note that Eden recently moved to an industrial biotech company, yet today refers to itself as a technology development and commercialisation company. It would be easier to be consistent with one description, whatever that may be

I'll read more later, but the request for more shares is the biggest concern, even if Eden say's it is a 'just in case'. I've heard that story too many times from too many companies. It's nearly always used, yet Eden has no apparent need for it unless we have pending a new strategic partner or one that wishes to increase their position, either way, at an unpalatable price if today's share price was to be the strike price

[investingisatrickygame] 30/5/2018 13:06

Super,

If anyone finds a replacement solution, they're a rich boy!!!

hxxps://www.transparencymarketresearch.com/glyphosate-market.html

[supersonico] 30/5/2018 10:50

The glyphosate substitute may not be another pesticide



AGRICULTURE - Allow yourself time to take stock of alternatives to glyphosate. This is essentially the response Minister Stéphane Travert made on Tuesday, June 20, to some of the deputies of the presidential majority.

They wanted to include in the law the ban of the famous pesticide in 2021. In short, to protect the promise of Emmanuel Macron: the end of glyphosate in France "within three years".

Finally, the National Assembly rejected the amendment, which was not desired by the government, and the Minister of Agriculture pledged to create a parliamentary committee to think about alternatives. Because that's the whole question. If France forbids glyphosate, the substance, with sulfur, the most used in agriculture, what will be the substitute?

Originally developed by Monsanto in its RoundUp, this herbicide penetrates the plant, kills it and prevents it from regrowing. In France, it is massively used, especially to clean a field of weeds before sowing.

Chemical alternatives even more risky
If it is so present, it is that glyphosate is easy to apply and cheap. In addition, it saves time and avoids having to work the land, which can damage it. If he is so criticized, it is because he is the center of an important scientific controversy.
In 2015, the International Agency for Research on Cancer, ICRC, classifies glyphosate as probably carcinogenic to humans. Attention, we are talking about the "direct" exposure of farmers, not of eating a product that has grown in a treated field. Since then, the decision has been criticized, especially by agro-industrialists, but not that, and a major study, also criticized by the other side, has said the opposite.
The fact remains that the European Union has chosen to renew the glyphosate license for 5 years. The French choice was therefore even more complicated to take, because in the event of a national ban, farmers risked being disadvantaged in the face of competition from neighboring countries.

Especially that the "substitutes" to the famous herbicide are not ready yet. In fact, there is no equivalent ... if not another herbicide, created by Bayer, the other big giant of the food industry: glufosinate ammonium. But is it safe? It is already difficult to answer on glyphosate, yet so much scrutinized and studied by many studies ...
Some studies in any case establish a possible risk for human health. Important enough to have convinced ANSES, the French regulatory agency, in October to ban Basta F1, a herbicide produced by Bayer and using just glufosinate ammonium. Better not to rely on this molecule.
Make something new with old
So what to do? In November, Philippe Mauguin, director of INRA, the research institute in agronomy, told parliamentarians that "there is no quick fix". And that his scientists do not work to "look for a molecule that would replace another molecule".

molecule that would replace another molecule ".
What then? The answer is in a report from INRA, submitted in December to the government. We learn that according to the researchers of the body, the solution will have to be multiple. Because glyphosate, more than any other pesticide, "combines many assets" difficult to replace.
It has made life easier for many farmers in very different situations. INRA has therefore considered several alternatives, alone or in combination. The physical and mechanical destruction of weeds, plowing, crop diversity. Or seedlings earlier in the season of species adapted to frost, to cut the grass under the foot of the bad ...
INRA also evokes automation, via robots and drones, to facilitate this physical work. In recent years, we have seen more and more germinate such ideas.
In short, a whole set of solutions that existed before, but brought up to date and based on new technologies and scientific knowledge. But we will have to adapt now that glyphosate has profoundly changed French agriculture. In particular improving the yield.

"So many situations that now find themselves in more or less marked difficulties and dead ends, we knew how to make agriculture before and we will know how to do it after ', but the changes in structure and organization experienced by French (and European) agriculture in recent decades, some of which made possible by the use of glyphosate, do not allow for a return to 'before' and force to build a different 'after'.
In parallel, in certain specific situations, where the options mentioned did not work, INRA recalls that it will surely be necessary, in this transition period, to use "other herbicides approved, but which may have toxicological profiles more unfavorable than that of glyphosate ".

Overall, INRA believes that "the exit of glyphosate will not be done by the use of a single option for all", but rather by identifying "locally adapted technical combinations". It will be complex. Especially during this transition period, it will also test a lot of options, we have not even imagined during the golden age of glyphosate.
It will take time and resources. It remains to be seen whether a law protecting this prohibition would have accelerated things or would have been counterproductive, favoring short-term solutions.

[supersonico] 28/5/2018 21:47

France must respect its commitment to leave glyphosate in 3 years, no later than the end of 2020

Macron had promised the ban on glyphosate but he is abdicating under the pressure of toxic industrialists like Monsanto. And there remains only our mobilization to block this powerful lobbying.

While the authorization of Monsanto's favorite glyphosate, the world's best-selling herbicide, was extended for five years in Europe last autumn, the president had immediately promised to ban it "at later in three years. "

The draft Agriculture and Food Law discussed in the National Assembly at this time offers the opportunity to realize this promise. The government is breaking this commitment because it refuses to put it in the bill.

But it's not too late.

A battle is going on right now between NGOs and lobbies to put this ban in the law. More than 50 members support an amendment that goes in that direction. They need us to support them and to convince other members. Time is running out, the vote must take place in the coming days.

Tell the government to respect Macron's commitment to ban glyphosate by 2020 at the latest.

Thank you for signing this urgent petition with our friends at Foodwatch and more than 30 NGOs to include the glyphosate ban in the law.

[supersonico] 28/5/2018 21:13

While the debate on the Agriculture and Food Law is underway in the Chamber of the National Assembly, a new disappointment has occurred!
Indeed, the Minister of Agriculture, Stéphane Travert, went down in front of the deputies Republicans and withdrew an amendment of the government - the scope yet limited - to finally take measures to protect the local residents vis-à- pesticides spread near homes.
This amendment, far from being revolutionary, introduced into the rural code the possibility for the administrative authority - namely the prefects - to prohibit or regulate the use of pesticides in areas' adjacent to inhabited buildings and non-residential areas. built, for use of pleasure, contiguous to these buildings. ". No compulsory constraint was therefore proposed, not even areas without treatment mentioned in this government amendment. And even this small advance, deputies (mostly Republicans), defenders of an old France, did not want and they informed the minister present in the hemicycle who complied with their request for withdrawal of the amendment.

"This position by Minister Travert is outrageous even though it was a promise made under the pesticide plan by government ministers. "Says F Veillerette Director of Generations Futures. "This withdrawal is all the more scandalous in this period of pesticide application, our associations are assailed messages of residents begging for help because they are victims of regular spraying while children play in the gardens adjoining cultivated areas. Let's remind the Minister that studies are underway within Public Health France because precisely this subject of exposure of residents to pesticides, considered vulnerable populations within the meaning of the European Regulation 1107/2009, is a concern of the health services . The recent report by IGAS and CGEDD clearly shows that dangerous substances are still used and impact populations. M Travert totally lacked political courage tonight and was not at the level of his mission being unable to find good arguments to defend the government amendment, he bears the heavy responsibility for this failure. He concludes.